How we know
Every link on this study, and who decided it
The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.
No reading has been made of this study yet; what is shown is how our rules link it today.
5 links0 made here, not in the record7 judgments1 judge (our rules as one)1 record change seen
Our rulesRecord updated on ClinicalTrials.gov
Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.
Carcinoma, Renal Cell
From the registry record2 judgments on this linkKind of condition link, from the registry to what was judged
RegistryCarcinoma, Renal Cell, once filedthe registry files the study under it
→judgedMain condition (R9)
→
On the pageNo longer linkedthe registry no longer files it here
All judgments on this study
| When | Link | Judge | Decision | State |
|---|---|---|---|---|
| Oct 20 | The record itself | ClinicalTrials.gov record | Version of 2026-10-20 | Record change |
| Nov 14 | Carcinoma, Renal Cell | Our condition-kind rule | Finest filed term | Current |
| As of now | Carcinoma, Renal Cell | Our main-condition rule (R9) | Main condition | Current |
| As of now | HMPL-013 | Our role rule | Tested | Current |
| As of now | HMPL-013 | Our role rule | Comparator | Current |
| As of now | Sintilimab | Our role rule | Tested | Current |
| As of now | Axitinib | Our role rule | Comparator | Current |
| As of now | Everolimus | Our role rule | Comparator | Current |